Hirschsprung's Disease: Causes, Symptoms, Diagnosis, and Treatment

What is Hirschsprung’s Disease?

Hirschsprung’s disease, also called congenital aganglionic megacolon or simply congenital megacolon, is a birth defect affecting the lower part of the large intestine. Its hallmark feature is the complete absence of normal nerve cell networks in a segment of the bowel, specifically the myenteric plexus of Auerbach and the submucosal plexus of Meissner.

These nerve plexuses are normally present throughout the entire intestine and are essential for coordinating peristalsis, the rhythmic, wave-like contractions that move digestive contents from the mouth toward the anus. Without these networks, the affected bowel segment cannot contract normally, leading to functional obstruction.

The name “congenital aganglionic megacolon” precisely describes the condition:

• Megacolon: A segment of the colon becomes abnormally enlarged due to functional obstruction.
• Congenital: The defect is present from birth, arising during fetal development.
• Aganglionic: The affected bowel lacks ganglia, which are clusters of nerve cells critical for regulating bowel movements.

Classification: Three Forms of Hirschsprung’s Disease

Physicians classify Hirschsprung’s disease into three main subtypes based on the length of the aganglionic bowel segment:

1. Classic (short-segment) form: The aganglionic zone is limited to the rectosigmoid region. This is the most common form, accounting for approximately 75–80% of cases.
2. Long-segment form: The affected area extends beyond the sigmoid colon into the descending colon. Occurs in approximately 15–20% of cases.
3. Total colonic aganglionosis: The entire large bowel is involved, and in rare cases, the small intestine may be affected too. This is the rarest and most severe form.

Underlying Mechanism

The disease results from a failure in the migration of neural crest cells (specifically the interstitial cells of Cajal) to the distal intestine during embryonic development. This leads to the permanent absence of ganglion cells in the affected bowel segment, preventing normal peristaltic coordination.

Clinical Overview

The main clinical features of Hirschsprung’s disease include:

• Failure to pass meconium (the newborn’s first stool) within the first 48 hours of life
• Progressive abdominal distension (a visibly swollen, bloated belly)
• Feeding refusal in the newborn
• Nausea and vomiting
• Paradoxical diarrhea (intermittent explosive stools despite underlying obstruction)
• General malaise and irritability
• Increased susceptibility to infections

Diagnosis relies on clinical assessment, radiological imaging (contrast enema), and confirmation through rectal biopsy, which remains the gold standard.

Treatment is surgical: the aganglionic bowel segment is removed and intestinal continuity is restored, either in a single-stage procedure or in two stages following a temporary colostomy.

With appropriate and timely surgical intervention, the prognosis is generally favorable. Mortality is rare, occurring in only approximately 3% of cases, typically in the context of severe complications such as enterocolitis.

---

Causes

Epidemiology

Hirschsprung’s disease occurs in approximately 1 in 4,500–5,000 live births, making it one of the most common causes of bowel obstruction in newborns. It shows a striking male predominance, with a male-to-female ratio of approximately 4:1. Interestingly, the female cases tend to involve longer aganglionic segments.

Genetic Basis

Because Hirschsprung’s disease is congenital, its root cause lies in genetic mutations affecting the development of the enteric nervous system during fetal life. Research over recent decades has identified several genes implicated in the condition:

• RET proto-oncogene: mutated in up to 70% of familial cases and approximately 15–35% of sporadic cases. RET mutations are the most significant known genetic factor.
• EDNRB gene (Endothelin receptor type B): mutations in this gene are associated with syndromic forms of the disease.
• ZFHX1B gene (also known as SIP1 or SMAD interacting protein 1), which is linked to Mowat-Wilson syndrome (see below).
• Additional genes including EDN3, GDNF, NRTN, SOX10, and PHOX2B have also been implicated.

These mutations lead to failure of neural crest cell migration, proliferation, differentiation, or survival in the developing gut, collectively termed neurocristopathy. The result is the permanent absence of enteric ganglion cells in the distal bowel.

Associated Genetic Syndromes

In approximately 12–15% of cases, Hirschsprung’s disease occurs as part of a broader genetic syndrome:

• Down syndrome (Trisomy 21): The most common chromosomal association; Hirschsprung’s disease is found in approximately 2–10% of individuals with Down syndrome.
• Ondine’s curse (Congenital Central Hypoventilation Syndrome): Associated with PHOX2B gene mutations.
• Waardenburg syndrome: Characterized by pigmentation abnormalities and sensorineural hearing loss, associated with EDNRB and SOX10 mutations.
• Mowat-Wilson syndrome: Associated with ZFHX1B gene mutations and intellectual disability.

Pathophysiology

The anatomical region most commonly affected is the rectosigmoid junction, the area where the sigmoid colon (named for its S-shaped resemblance to the Greek letter sigma) meets the rectum. The absence of nerve plexuses at this level means the bowel cannot generate effective peristaltic waves.

As a result:

• Intestinal contents cannot be propelled toward the anus.
• Stool and gas accumulate proximally, causing chronic distension.
• The bowel wall is progressively stretched and weakened.
• In advanced stages, this leads to a massively dilated megacolon at risk of perforation, a life-threatening emergency.

---

Symptoms

The clinical presentation of Hirschsprung’s disease is variable, depending largely on the length of the aganglionic segment and how effectively the remaining bowel can compensate. However, the majority of cases manifest in the first days or months of life.

1. Delayed Passage of Meconium: The Key Early Warning Sign

Meconium is the dark greenish-black, sticky substance that constitutes a newborn’s first bowel movement. In healthy newborns, meconium is typically passed within 24–48 hours of birth.

In Hirschsprung’s disease, failure to pass meconium within the first 48 hours is a critical red flag. When this occurs alongside abdominal distension, it is termed meconium ileus, a form of intestinal obstruction also seen in cystic fibrosis.

Important: Approximately 94% of healthy full-term newborns pass meconium within 24 hours. Failure to do so should always prompt investigation.

2. Acute Intestinal Obstruction: A Surgical Emergency

In severe cases, gas and feces accumulate extensively in the rectosigmoid area, leading to complete intestinal obstruction. Clinical manifestations include:

• Abdominal distension: the abdomen becomes visibly and severely bloated
• Abdominal pain: manifesting as inconsolable crying in infants
• Fever, nausea, and vomiting (particularly bilious vomiting)
• Feeding refusal
• Complete absence of stool and gas passage
• Rapid clinical deterioration of the newborn’s general condition

This acute presentation constitutes a medical and surgical emergency, requiring prompt intervention to prevent bowel perforation and life-threatening enterocolitis.

3. Paradoxical Sub-obstruction (Partial Obstruction)

Some infants pass meconium partially but continue to experience chronic symptoms including intermittent gas passage and chronic diarrhea. In this scenario, the bowel functions, but only partially and inadequately. This condition may respond temporarily to enemas and laxatives, allowing time for a planned surgical procedure once diagnosis is confirmed.

4. Mild, Chronic Sub-obstruction

In some cases, particularly those with short aganglionic segments, the clinical picture is more subtle and insidious:

• The infant achieves bowel movements intermittently, alternating with periods of obstruction
• Progressive abdominal bloating
• Bacterial overgrowth due to stagnant intestinal contents (risk of Hirschsprung-associated enterocolitis)
• Delayed growth and weight gain (failure to thrive)
• Symptoms mimicking anorexia, anemia, and recurrent infections

Hirschsprung-associated enterocolitis (HAEC) deserves special mention. It is one of the most feared complications, occurring in up to 30–40% of patients even after surgery. It presents with explosive foul-smelling diarrhea, fever, and abdominal distension, and can rapidly become life-threatening without treatment.

---

Diagnosis

Clinical Assessment

Diagnosis begins with a careful clinical history and physical examination. The combination of:

• Delayed meconium passage (beyond 48 hours)
• Abdominal distension
• Failure to thrive

…should immediately raise suspicion for Hirschsprung’s disease.

Digital rectal examination is highly informative: in Hirschsprung’s disease, the physician will note:

• Increased sphincter tone (abnormally tight anal sphincter)
• Empty rectal ampulla (no stool present in the rectum, indicating a blockage further up in the sigmoid)
• Often followed by an explosive discharge of gas and stool upon withdrawal of the finger, the so-called “blast sign”

Contrast Enema (Barium or Water-Soluble Enema)

A contrast enema (formerly known as a barium enema) is a radiological examination in which contrast material is introduced into the bowel via a catheter, followed by X-ray imaging of the lower abdomen.

In Hirschsprung’s disease, this study typically reveals:

• A narrow, spastic distal segment (the aganglionic zone)
• A dilated proximal bowel (the normally innervated, distended colon above the obstruction)
• A characteristic “transition zone”: the cone-shaped area where the bowel transitions from narrow to wide
• The narrow aganglionic segment appears as a thin, irregular line, classically described as a “rat-tail” or “mouse-tail” appearance

Note: In neonates, the transition zone may not always be visible immediately after birth, as the proximal bowel may not yet have dilated sufficiently. Repeat imaging at 24 hours may be necessary.

Anorectal Manometry

Anorectal manometry measures the pressure dynamics of the rectum and anal sphincter. In healthy individuals, rectal distension triggers relaxation of the internal anal sphincter (the rectoanal inhibitory reflex, RAIR). In Hirschsprung’s disease, this reflex is absent, which is a highly sensitive and specific finding.

Rectal Biopsy: The Gold Standard

The definitive diagnosis of Hirschsprung’s disease is established by rectal suction biopsy, which examines a small tissue sample from the rectal wall.

Histopathological analysis will confirm:

• Complete absence of ganglion cells in both the myenteric and submucosal plexuses
• Hypertrophy of nerve fibers
• Increased acetylcholinesterase activity in nerve fibers, demonstrated by special histochemical staining

This finding is pathognomonic (definitively characteristic) of Hirschsprung’s disease.

Differential Diagnosis

Hirschsprung’s disease must be distinguished from other conditions presenting with similar features:

---

Treatment

Surgical Approach: The Cornerstone of Management

The treatment of Hirschsprung’s disease is exclusively surgical. There is no effective long-term medical management for the underlying defect. The goal of surgery is to:

1. Remove the aganglionic bowel segment (the section lacking nerve cells)
2. Restore intestinal continuity by connecting the healthy, normally innervated bowel to the anus

Stage 1: Emergency Decompression (when needed)

In cases presenting with acute bowel obstruction or life-threatening enterocolitis, the first priority is bowel decompression. This is achieved through a diverting colostomy, a surgical procedure in which the healthy colon above the aganglionic segment is brought to the surface of the abdominal wall (the skin). This creates a temporary stoma through which gas and stool can pass and be collected in a specialized pouch.

This procedure is life-saving and must be performed as quickly as possible in acute presentations.

Stage 2: Definitive Pull-Through Surgery

Once the patient is stabilized and has grown sufficiently (typically after a few months in neonates), definitive corrective surgery is performed. This is the so-called “pull-through” procedure.

Several techniques have been developed:

• Swenson procedure: Original technique (1948); involves resection of the aganglionic segment down to the anus
• Duhamel procedure: The normally innervated colon is brought behind the rectum and joined to it
• Soave procedure (endorectal pull-through): The rectal mucosa is stripped, and the healthy colon is pulled through the remaining rectal muscle cuff

Today, many centers perform minimally invasive (laparoscopic or transanal) pull-through procedures, which reduce recovery time, scarring, and complications.

Single-Stage vs. Two-Stage Surgery

In selected patients, particularly those diagnosed early with good nutritional status and without enterocolitis, single-stage surgery (pull-through without prior colostomy) can be performed safely, even in the neonatal period.

In more complex cases, a two-stage approach is preferred:

1. Initial colostomy for decompression
2. Definitive pull-through procedure after an interval of several weeks or months

Post-Operative Care and Long-Term Outcomes

After surgery, most children achieve normal or near-normal bowel function. However, some may experience:

• Constipation (the most common long-term issue)
• Fecal soiling or incontinence (particularly in early childhood)
• Recurrent Hirschsprung-associated enterocolitis (HAEC): this requires prompt treatment with bowel washouts, antibiotics, and occasionally further surgery
• Anastomotic stricture: narrowing at the surgical join, which may require dilation

Regular follow-up with a pediatric gastroenterologist and surgeon is essential.

Prognosis

With modern surgical techniques and multidisciplinary care:

• The vast majority of patients lead healthy, normal lives
• Overall mortality is approximately 3%, occurring mainly in the setting of severe enterocolitis or total colonic aganglionosis
• Long-term quality of life is generally good, though some children require ongoing management of bowel habits throughout childhood

---

Sources and Bibliography

• Patel, S., Léger, J., et al. - Surgical Pathology (Patologia chirurgica: Patel-Leger e coll., Ed. Masson)
• Dionigi, R. Surgery: Theoretical Foundations and General Surgery – Specialized Surgery, Vol. 1–2 (Chirurgia. Basi teoriche e chirurgia generale – Chirurgia specialistica, Ed. Elsevier)
• Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet. 2001;38(11):729-739.
• Langer JC. Hirschsprung disease. Curr Opin Pediatr. 2013;25(3):368-374.
• Kapur RP. Practical pathology and genetics of Hirschsprung’s disease. Semin Pediatr Surg. 2009;18(4):212-223.
• World Journal of Gastroenterology: Hirschsprung’s Disease Review. https://www.wjgnet.com
• National Organization for Rare Disorders (NORD), Hirschsprung Disease. https://rarediseases.org/rare-diseases/hirschsprung-disease/
• MedlinePlus (U.S. National Library of Medicine: Hirschsprung Disease. https://medlineplus.gov/hirschisprungsdisease.html
• Gosain A, Frykman PK, Cowles RA, et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517-521.